March 3 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Autodesk, Fedex and Morgan Stanley Direct Lending Fund, on Monday.
HIGHLIGHTS
* Autodesk Inc ADSK.O: HSBC cuts target price to $275 from $290 |
* Brown-Forman Corp BFb.N: RBC cuts target price to $44 from $49 |
* Fedex Corp FDX.N: JP Morgan cuts target price to $323.00 from $372.00 |
* Morgan Stanley Direct Lending Fund MSDL.N: JP Morgan cuts PT to $20.50 from $21.00 |
* Openlane Inc KAR.N: Stephens raises to overweight from equal weight |
Following is a summary of research actions on U.S. companies reported by Reuters on Monday. Stock entries are in alphabetical order.
* 4D Molecular Therapeutics Inc FDMT.O: RBC cuts target price to $35 from $39 |
* Abercrombie & Fitch Co ANF.N: Raymond James cuts PT to $124.00 from $165.00 |
* Acadia Healthcare Company Inc ACHC.O: Raymond James cuts PT to $40.00 from $65.00 |
* Acadia Healthcare Company Inc ACHC.O: RBC cuts target price to $43 from $64 |
* Acadia Healthcare Company Inc ACHC.O: UBS cuts target price to $45 from $70 |
* ACNB Corp ACNB.O: Piper Sandler raises target price to $50 from $37 |
* ACNB Corp ACNB.O: Piper Sandler raises to overweight from neutral |
* AES Corp AES.N: Seaport Research Partners cuts to sell from neutral |
* Akero Therapeutics Inc AKRO.O: H.C. Wainwright raises PT to $75 from $72 |
* Alphatec Holdings Inc ATEC.O: Jefferies raises target price to $22 from $19 |
* American Airlines AAL.O: JP Morgan cuts target price to $26 from $30 |
* Amplitude Inc AMPL.O: Needham initiates coverage with buy rating; target price $16 |
* Anaptysbio Inc ANAB.O: Guggenheim raises target price to $52 from $36 |
* ANI Pharmaceuticals Inc ANIP.O: Raymond James raises PT to $84.00 from $83.00 |
* Apellis Pharmaceuticals Inc APLS.O: Wedbush cuts target price to $29 from $30 |
* Apogee Therapeutics Inc APGE.O: Guggenheim raises PT to $116 from $110 |
* Ardent Health Partners Inc ARDT.N: Leerink Partners cuts target price to $21 from $25 |
* Arhaus Inc ARHS.O: Stifel cuts target price to $11.5 from $14 |
* Array Technologies Inc ARRY.O: Truist Securities cuts target price to $8 from $10 |
* Astrana Health Inc ASTH.O: TD Cowen cuts target price to $40 from $66 |
* AT&T Inc T.N: Scotiabank raises target price to $28.50 from $26 |
* Autodesk Inc ADSK.O: HSBC cuts target price to $275 from $290 |
* Bain Capital Specialty Finance Inc BCSF.N: Wells Fargo raises PT to $19 from $18 |
* Beam Therapeutics Inc BEAM.O: Scotiabank raises target price to $25 from $24 |
* BJ's Wholesale Club Holdings Inc BJ.N: JP Morgan raises PT to $101 from $87 |
* Brown-Forman Corp BFb.N: RBC cuts target price to $44 from $49 |
* Buckle Inc BKE.N: UBS cuts target price to $43 from $52 |
* Bunge Global SA BG.N: UBS cuts target price to $100 from $115 |
* C4 Therapeutics Inc CCCC.O: UBS cuts target price to $3.5 from $4 |
* Cable One Inc CABO.N: JP Morgan cuts target price to $325.00 from $420.00 |
* Cable One Inc CABO.N: TD Cowen cuts target price to $448 from $465 |
* Caredx Inc CDNA.O: H.C. Wainwright cuts target price to $25 from $26 |
* Chart Industries Inc GTLS.N: HSBC raises target price to $215 from $205 |
* Chart Industries Inc GTLS.N: Wells Fargo cuts target price to $214 from $215 |
* Chipotle Mexican Grill CMG.N: Morgan Stanley raises PT to $70.00 from $65.00 |
* Chipotle Mexican Grill CMG.N: Morgan Stanley raises to overweight from equal-weight |
* Crowdstrike CRWD.O: Canaccord Genuity raises target price to $420 from $370 |
* Darling Ingredients Inc DAR.N: UBS cuts target price to $58 from $63 |
* Definitive Healthcare DH.O: Deutsche Bank cuts target price to $4 from $5 |
* Denali Therapeutics DNLI.O: Deutsche Bank cuts target price to $29 from $31 |
* Denali Therapeutics DNLI.O: Oppenheimer cuts target price to $42 from $50 |
* Disc Medicine Inc IRON.O: Scotiabank raises target price to $75 from $73 |
* Docebo Inc DCBO.O: CIBC cuts target price to $48 from $60 |
* Doubleverify Holdings DV.N: BofA Global Research raises to neutral from underperform |
* Doubleverify Holdings DV.N: BofA Global Research cuts PT to $17 from $19 |
* eBay EBAY.O: Susquehanna raises target price to $65 from $60 |
* Ecolab Inc ECL.N: BMO raises target price to $305 from $295 |
* Ecovyst Inc ECVT.N: BMO cuts target price to $9 from $11 |
* Edison International EIX.N: Mizuho cuts target price to $66 from $75 |
* Enovis Corp ENOV.N: Jefferies cuts target price to $70 from $75 |
* EOG Resources Inc EOG.N: JP Morgan raises target price to $149 from $144 |
* Equinix Inc EQIX.O: Scotiabank raises target price to $1,040 from $1,033 |
* Expand Energy Corp EXE.O: UBS raises target price to $138 from $133 |
* Federal Signal Corp FSS.N: D.A. Davidson cuts target price to $82 from $90 |
* Fedex Corp FDX.N: JP Morgan cuts target price to $323.00 from $372.00 |
* First Advantage Corp FA.O: BMO cuts target price to $22 from $24 |
* Five Below Inc FIVE.O: Truist Securities cuts target price to $93 from $118 |
* Fox Factory Holding Corp FOXF.O: Jefferies cuts target price to $38 from $45 |
* FTAI Aviation Ltd FTAI.O: Stifel cuts to hold from buy |
* FTAI Aviation Ltd FTAI.O: Stifel raises target price to $123 from $100 |
* GE Vernova Inc GEV.N: Barclays cuts target price to $427 from $487 |
* GE Vernova Inc GEV.N: BMO cuts target price to $420 from $471 |
* Gilead GILD.O: Jefferies raises target price to $130 from $115 |
* Greif Inc GEF.N: Truist Securities cuts target price to $65 from $71 |
* Greif Inc GEF.N: Wells Fargo cuts target price to $75 from $76 |
* Grindr Inc GRND.N: TD Cowen raises target price to $20 from $18 |
* HCI Group Inc HCI.N: Oppenheimer raises target price to $165 from $150 |
* Heico Corp HEI.N: UBS raises target price to $279 from $254 |
* Hubbell Inc HUBB.N: Barclays cuts target price to $422 from $475 |
* Idacorp Inc IDA.N: BofA Global Research raises PT to $127 from $119 |
* Installed Building Products Inc IBP.N: Truist Securities cuts PT to $180 from $240 |
* Integral Ad Science Holding IAS.O: Morgan Stanley raises PT to $13.50 from $13.00 |
* Integral Ad Science Holding IAS.O: Truist Securities raises PT to $17 from $16 |
* International Money Express Inc IMXI.O: Needham cuts target price to $20 from $25 |
* Intuit Inc INTU.O: Mizuho raises target price to $765 from $750 |
* Iovance Biotherapeutics Inc IOVA.O: Truist Securities cuts PT to $15 from $25 |
* Kimbell Royalty Partners KRP.N: Raymond James cuts to market perform from strong buy |
* Leslie's Inc LESL.O: Morgan Stanley cuts target price to $1.50 from $3.00 |
* Life Time Group LTH.N: Deutsche Bank raises target price to $36 from $34 |
* LSB Industries LXU.N: Deutsche Bank cuts target price to $9 from $10 |
* Main Street Capital Corp MAIN.N: Truist Securities raises PT to $62 from $52 |
* Marathon Digital Holdings Inc MARA.O: Piper Sandler cuts target price to $30 from $34 |
* Maravai Lifesciences Holdings MRVI.O: BofA Global Research cuts PT to $8 from $9 |
* Mastec Inc MTZ.N: Citigroup raises target price to $167 from $156 |
* Mastec Inc MTZ.N: Stifel cuts target price to $175 from $185 |
* Mastec Inc MTZ.N: Truist Securities raises target price to $197 from $189 |
* Molina Healthcare Inc MOH.N: Mizuho cuts target price to $376 from $382 |
* Morgan Stanley Direct Lending Fund MSDL.N: JP Morgan cuts PT to $20.50 from $21.00 |
* Morgan Stanley Direct Lending Fund MSDL.N: Wells Fargo cuts PT to $20 from $21 |
* Morningstar Inc MORN.O: BMO cuts target price to $370 from $387 |
* Mosaic Co MOS.N: JP Morgan raises to overweight from neutral |
* Mosaic Co MOS.N: Mizuho cuts target price to $28 from $29 |
* Mosaic Co MOS.N: Scotiabank cuts target price to $31 from $34 |
* Myriad Genetics Inc MYGN.O: BofA Global Research cuts PT to $11 from $13 |
* N-Able Inc NABL.N: Needham cuts target price to $10 from $16.50 |
* NRG Energy Inc NRG.N: BMO raises target price to $115 from $100 |
* Openlane Inc KAR.N: Stephens raises target price to $26 from $20 |
* Openlane Inc KAR.N: Stephens raises to overweight from equal weight |
* Oracle Corp ORCL.N: Monness Crespi Hardt raises to neutral from sell |
* Ormat Technologies Inc ORA.N: UBS cuts target price to $100 from $106 |
* Papa John's International Inc PZZA.O: Stephens cuts PT to $58 from $60 |
* Penn Entertainment Inc PENN.O: Wells Fargo raises PT to $24 from $20 |
* Praxis Precision Medicines Inc PRAX.O: Deutsche Bank cuts PT to $65 from $111 |
* Praxis Precision Medicines Inc PRAX.O: Guggenheim cuts PT to $120 from $170 |
* Praxis Precision Medicines Inc PRAX.O: H.C. Wainwright cuts PT to $105 from $120 |
* Praxis Precision Medicines Inc PRAX.O: Jefferies cuts PT to $105 from $305 |
* Praxis Precision Medicines Inc PRAX.O: Needham cuts PT to $85.00 from $150.00 |
* Praxis Precision Medicines Inc PRAX.O: TD Cowen cuts target price to $61 from $114 |
* Praxis Precision Medicines Inc PRAX.O: Truist Securities cuts PT to $85 from $175 |
* Protagonist Therapeutics Inc PTGX.O: JP Morgan raises target price to $57 from $53 |
* Public Service Enterprise Group PEG.N: BofA Global Research cuts PT to $92 from $95 |
* Pubmatic Inc PUBM.O: Jefferies cuts target price to $12 from $16 |
* Redfin Corp RDFN.O: Susquehanna cuts target price to $7 from $10 |
* Revolution Medicines Inc RVMD.O: H.C. Wainwright raises target price to $73 from $72 |
* Rhythm Pharmaceuticals Inc RYTM.O: H.C. Wainwright raises PT to $70 from $69 |
* Rocket Lab USA Inc RKLB.O: Wells Fargo cuts target price to $21 from $22 |
* Rocket Pharmaceuticals Inc RCKT.O: Scotiabank raises target price to $52 from $51 |
* Seacoast Banking Corporation of Florida SBCF.O: Stephens raises PT to $29 from $28 |
* Skyward Specialty Insurance Group SKWD.O: Raymond James raises PT to $60 from $55 |
* Southwest Airlines Co LUV.N: JP Morgan cuts to underweight from neutral |
* Strategic Education Inc STRA.O: BMO cuts target price to $97 from $114 |
* Sunnova Energy International Inc NOVA.N: JP Morgan cuts to neutral from overweight |
* Sunrun Inc RUN.O: BMO cuts target price to $9 from $11 |
* Sunrun Inc RUN.O: Truist Securities cuts target price to $9 from $12 |
* Tandem Diabetes Care Inc TNDM.O: Wells Fargo cuts target price to $22 from $38 |
* Teleflex Inc TFX.N: Truist Securities cuts target price to $149 from $200 |
* Tempus AI Inc TEM.O: BofA Global Research raises price objective to $60 from $54 |
* Tesla Inc TSLA.O: Morgan Stanley reinstates stock as 'top pick' in U.S. autos |
* The Bank of New York Mellon Corporation BK.N: Wells Fargo raises PT to $96 from $86 |
* Thor Industries Inc THO.N: BofA Global Research raises PT to $125 from $110 |
* Thor Industries Inc THO.N: BofA Global Research raises to buy from neutral |
* Tidewater Inc TDW.N: Raymond James cuts target price to $76 from $95 |
* T-Mobile TMUS.O: Scotiabank raises target price to $275 from $247 |
* Topbuild Corp BLD.N: Jefferies cuts target price to $400 from $470 |
* Treace Medical Concepts Inc TMCI.O: Truist Securities raises PT to $10 from $8.4 |
* Tuhura Biosciences Inc HURA.O: H.C. Wainwright initiates coverage with buy rating |
* TXNM Energy Inc TXNM.N: Mizuho raises target price to $53 from $50 |
* Universal Health Services Inc UHS.N: TD Cowen cuts target price to $226 from $251 |
* Unum Group UNM.N: BMO raises target price to $102 from $95 |
* Vericel Corp VCEL.O: Truist Securities cuts target price to $61 from $67 |
* Verizon VZ.N: Scotiabank raises target price to $48 from $47.50 |
* Vertiv Holdings Co VRT.N: Barclays cuts target price to $111 from $131 |
* Visteon Corp VC.O: JP Morgan cuts target price to $105 from $108 |
* Watts Water Technologies Inc WTS.N: TD Cowen raises target price to $180 from $175 |
* Wynn Resorts Ltd WYNN.O: UBS raises target price to $89 from $86 |
* Zoominfo Technologies ZI.O: Deutsche Bank raises target price to $14 from $12 |
* zSpace ZSPC.O: Barrington Research initiates coverage with outperform rating; PT $18 |
(Compiled by Bengaluru Newsroom)
((Diaries@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.